Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category

Results 1 - 100 of 5394

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
Bayer Pipeline, Products ,Performance ,Potential	Oct 2009	£595
Boehringer Ingelheim: Pipeline, Products, Performance, Potential	Sep 2009	£595
Zelos Therapeutics Inc.-Company Report	Sep 2009	£460
Zenotech Laboratories Ltd.-Company Report	Sep 2009	£460
Zealand Pharma A/S-Company Report	Sep 2009	£460
ZARS Pharma-Company Report	Sep 2009	£460
Zambon Company S.p.A.-Company Report	Sep 2009	£460
Zentiva, a.s. (formerly Leciva a.s.)-Company Report	Sep 2009	£460
Zeria Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£460
Cornerstone Therapeutics Inc.-Detailed Product Pipeline	Sep 2009	£475
Crown Laboratories, Inc.-Company Report	Sep 2009	£475
Zhejiang Huahai Pharmaceutical Co.,Ltd-Company Report	Sep 2009	£460
Zahravi Pharmaceutical Company-Company Report	Sep 2009	£460
Zenyaku Kogyo Co. Ltd.-Company Report	Sep 2009	£460
Zyber Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
Eusa Pharma (Europe) Ltd.-Company Report	Sep 2009	£455
Indus Biotech Private Limited-Company Report	Sep 2009	£455
Sucampo Pharmaceuticals, Inc.-Deals & Alliances Report	Sep 2009	£365
Zymenex A/S-Company Report	Sep 2009	£460
ZOLL Medical Corp.-Deals & Alliances Report	Sep 2009	£370
Facet Biotech Corporation-Therapeutic Competitors	Sep 2009	£215
Cleveland Biolabs, Inc.-Deals & Alliances Report	Sep 2009	£380
CombinatoRx Inc-Therapeutic Competitors	Sep 2009	£220
Cellceutix Corporation-Therapeutic Competitors	Sep 2009	£220
Cellceutix Corporation-Detailed Product Pipeline	Sep 2009	£475
Zhuzhou Qianjin Pharmaceutical Co.,Ltd-Company Report	Sep 2009	£460
Cardinal Health, Inc.-Deals & Alliances Report	Sep 2009	£380
Ceragenix Pharmaceuticals, Inc.-Deals & Alliances Report	Sep 2009	£380
CerRx, Inc.-Company Report	Sep 2009	£475
Changzhou Fangyuan Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£475
Charleston Laboratories, Inc.-Company Report	Sep 2009	£475
China Biopharma Inc-Therapeutic Competitors	Sep 2009	£220
Centocor Ortho Biotech Inc.-Company Report	Sep 2009	£475
Celentyx Limited-Company Report	Sep 2009	£475
Obagi Medical Products Inc-Detailed Product Pipeline	Sep 2009	£460
PharmaEssentia Corporation-Company Report	Sep 2009	£460
Biostar Pharmaceuticals, Inc.-Therapeutic Competitors	Sep 2009	£220
Cryo-Cell International Inc.-Deals & Alliances Report	Sep 2009	£380
Combe Incorporated-Company Report	Sep 2009	£475
Consilient Health Ltd.-Company Report	Sep 2009	£475
Camus Pharma Pvt. Ltd.-Company Report	Sep 2009	£475
BioTime, Inc.-Deals & Alliances Report	Sep 2009	£380
BioTime Inc-Therapeutic Competitors	Sep 2009	£220
Biovail Corporation-Therapeutic Competitors	Sep 2009	£220
Calistoga Pharmaceuticals, Inc.-Company Report	Sep 2009	£475
Calmune Corporation-Company Report	Sep 2009	£475
China Biologic Products, Inc.-Detailed Product Pipeline	Sep 2009	£475
China Biologic Products, Inc.-Therapeutic Competitors	Sep 2009	£220
Burzynski Research Institute, Inc-Company Report	Sep 2009	£475
C.B. Fleet Company, Inc.-Company Report	Sep 2009	£475
Zydus Cadila Healthcare Limited-Company Report	Sep 2009	£460
Vemedia B.V.-Company Report	Sep 2009	£460
Bio-Med Private Limited-Company Report	Sep 2009	£475
Bio-K+ International Inc.-Company Report	Sep 2009	£475
BioSphere Medical Inc.-Deals & Alliances Report	Sep 2009	£380
Biostar Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£475
BIOALVO-Company Report	Sep 2009	£475
Biokine Therapeutics Ltd.-Company Report	Sep 2009	£475
Biochem Pharmaceutical Industries Ltd.-Company Report	Sep 2009	£475
Bio3 Research S.r.l.-Company Report	Sep 2009	£475
BioClinica, Inc.-Deals & Alliances Report	Sep 2009	£380
BioArctic Neuroscience AB-Company Report	Sep 2009	£475
BioCis Pharma Ltd.-Company Report	Sep 2009	£475
Bial Group-Company Report	Sep 2009	£475
Azaya Therapeutics, Inc.-Company Report	Sep 2009	£475
APEX Pharma S.A.E.-Company Report	Sep 2009	£475
Atra Pharmaceuticals Pvt. Ltd.-Company Report	Sep 2009	£475
Aus Bio Limited-Company Report	Sep 2009	£475
Azevan Pharmaceuticals, Inc.-Company Report	Sep 2009	£475
Advanced in vitro cell technologies, s.l. (Advancell)-Company Report	Sep 2009	£475
Advance Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£475
TomoTherapy Incorporated-Deals & Alliances Report	Sep 2009	£370
Actis Biologics, Inc.-Company Report	Sep 2009	£475
AMDL, Inc.-Deals & Alliances Report	Sep 2009	£380
Adnexus Therapeutics, Inc.-Company Report	Sep 2009	£475
Tragara Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
Transave, Inc.-Company Report	Sep 2009	£460
Trinity Biotech plc-Deals & Alliances Report	Sep 2009	£370
Transport Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
Translational Research, Ltd.-Company Report	Sep 2009	£460
TransDermal Technologies, Inc.-Company Report	Sep 2009	£460
Trigen Pharma International-Company Report	Sep 2009	£460
Trius Therapeutics (formerly Rx3 Pharmaceuticals, Inc.)-Company Report	Sep 2009	£460
Tyco International Ltd.-Deals & Alliances Report	Sep 2009	£370
Twinstrand Therapeutics-Company Report	Sep 2009	£460
Transcept Pharmaceuticals, Inc.-Therapeutic Competitors	Sep 2009	£215
Transcept Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£460
UAS Laboratories-Company Report	Sep 2009	£460
Unigene Laboratories Inc.-Deals & Alliances Report	Sep 2009	£370
United Therapeutics Corp.-Deals & Alliances Report	Sep 2009	£370
United Pharmaceuticals-Company Report	Sep 2009	£460
Uni-Bio Science Group Ltd.-Company Report	Sep 2009	£460
UNI PHARMA-Company Report	Sep 2009	£460
Vaishnavi Lifescience Pvt. Ltd.-Company Report	Sep 2009	£460
Validus Pharmaceuticals, Inc.-Company Report	Sep 2009	£460
Vectura Group plc-Company Report	Sep 2009	£460
VectorLogics, Inc.-Company Report	Sep 2009	£460
Varian Inc.-Deals & Alliances Report	Sep 2009	£370
Varian Medical Systems Inc.-Deals & Alliances Report	Sep 2009	£370
YuYu Inc.-Company Report	Sep 2009	£460